# MBX Biosciences, Inc.: Form 8-K, filed Feb 27, 2026

- Company: [MBX Biosciences, Inc.](/companies/mbx.md) (CIK 1776111)
- Form: 8-K
- Filed: 2026-02-27
- Accepted by EDGAR: Feb 27, 2026, 07:54 ET
- Period: 2026-02-24
- Accession: 0001193125-26-079286
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1776111/000119312526079286/mbx-20260224.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776111/000119312526079286/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776111/000119312526079286/mbx-20260224.htm

Filed Feb 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-079286. Last ingested by Listed: Nov 4, 2026, 15:47 ET. No prices; not investment advice.